A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs
NCT ID: NCT03201718
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
505 participants
OBSERVATIONAL
2017-08-17
2019-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
NCT03740230
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)
NCT03002818
Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B
NCT03050905
Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment
NCT02397707
Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea
NCT02727933
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepatitis C
Participants with Hepatitis C receiving Viekira/Exviera (paritaprevir/ritonavir/ombitasvir and dasabuvir) for 12 or 24 weeks.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants prescribed Viekira/Exviera in accordance with approved local label
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AbbVie Inc.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dong-A University Hospital /ID# 167362
Busan, Busan Gwang Yeogsi, South Korea
Pusan National University Hosp /ID# 167363
Busan, Busan Gwang Yeogsi, South Korea
Kyungpook National Univ Hosp /ID# 168731
Daegu, Daegu Gwang Yeogsi, South Korea
Yeungnam University Med Ctr /ID# 167425
Daegu, Daegu Gwang Yeogsi, South Korea
Chungnam National University Hospital /ID# 167724
Junggu, Daejeon Gwang Yeogsi, South Korea
National health insurance cooperation ilsan hospital /ID# 201806
Goyang, Gyeonggido, South Korea
Soon Chun Hyang University Hospital Bucheon /ID# 201803
Habun, Gyeonggido, South Korea
Seoul National Univ Bundang ho /ID# 167394
Seongnam, Gyeonggido, South Korea
St. Vincent's Hospital /ID# 201660
Suwon, Gyeonggido, South Korea
Ajou University Hospital /ID# 167729
Suwon, Gyeonggido, South Korea
Inje University Busan Paik Hospital /ID# 167392
Pusan, Gyeongsangbuk-do, South Korea
Changwon Fatima Hospital /ID# 201664
Changwon, Gyeongsangnam-do, South Korea
Inha University Hospital /ID# 201802
Junggu, Incheon Gwang Yeogsi, South Korea
Chonnam National University Hospital /ID# 167423
Gwangju, Jeonranamdo, South Korea
Kwangju Christian Hospital /ID# 210823
Gwangju, Jeonranamdo, South Korea
Kyungpook National University Chilgok Hospital /ID# 201804
Daegu, Seoul Teugbyeolsi, South Korea
SMG-SNU Boramae Medical Center /ID# 201805
Dongjak-gu, Seoul Teugbyeolsi, South Korea
Kangbuk Samsung Hospital /ID# 168792
Jongno-Gu, Seoul Teugbyeolsi, South Korea
Severance Hospital /ID# 167361
Seoul, Seoul Teugbyeolsi, South Korea
Konkuk University Medical Ctr /ID# 167723
Seoul, Seoul Teugbyeolsi, South Korea
Samsung Medical Center /ID# 167722
Seoul, Seoul Teugbyeolsi, South Korea
Korea Universtiy Guro Hospital /ID# 167388
Seoul, Seoul Teugbyeolsi, South Korea
Bucheon St. Mary's hospital /ID# 170782
Bucheon-si, , South Korea
Dongnam Institute of Radiologi /ID# 167721
Busan, , South Korea
Good Samsun Hospital /ID# 167365
Busan, , South Korea
Haeundae Paik Hospital /ID# 170767
Busan, , South Korea
Maryknoll Medical Center /ID# 167418
Busan, , South Korea
Kosin University Gospel Hosp /ID# 168797
Busan, , South Korea
Samsung Changwon Hospital /ID# 167732
Changwon, , South Korea
Dankook University Hospital /ID# 167730
Cheonan, , South Korea
Chuncheon Sacred Heart Hosp /ID# 167419
Chuncheon, , South Korea
Kim Jun Hwan Sok Internal Medi /ID# 168794
Daegu, , South Korea
Keimyung Univ Dongsan medical /ID# 168793
Daegu, , South Korea
Daegu Catholic University Med /ID# 167714
Daegu, , South Korea
Daegu Catholic University Med /ID# 168729
Daegu, , South Korea
The Catholic Univ. of Korea /ID# 167733
Daejeon, , South Korea
Dongguk University Ilsan Hosp /ID# 168795
Goyang, , South Korea
Myongji Hospital /ID# 170784
Goyang, , South Korea
CHA Gumi Medical Center /ID# 170783
Gumi, , South Korea
Korea University Ansan Hosp /ID# 201661
Gyeonggi-do, , South Korea
Dongtan Sacred Heart Hospital /ID# 170759
Hwaseong, , South Korea
The Catholic University of Korea Incheon St.Mary's Hospital /ID# 170769
Incheon, , South Korea
Presbyterian Medical Center /ID# 167424
Jeonju, , South Korea
CHA Bundang Medical Center /ID# 170757
Seongnam, , South Korea
Bundang Jesaeng hospital /ID# 167725
Seongnam, , South Korea
Korea University Anam Hospital /ID# 167731
Seoul, , South Korea
Seoul National University Hospital /ID# 167364
Seoul, , South Korea
Seoul National University Hospital /ID# 167389
Seoul, , South Korea
SoonChunHyang University Seoul /ID# 167711
Seoul, , South Korea
Asan Medical Center /ID# 167390
Seoul, , South Korea
Chung-Ang University Hostipal /ID# 167420
Seoul, , South Korea
Inje University Seoul Paik Hos /ID# 167426
Seoul, , South Korea
Inje University Sanggye Paik H /ID# 167427
Seoul, , South Korea
St. Carollo General Hospital /ID# 167712
Suncheon, , South Korea
Uijeongbu St. Mary's Hospital /ID# 168730
Uijeongbu-si, , South Korea
Ulsan University Hospital /ID# 168796
Ulsan, , South Korea
Wonju Severance Christian Hosp /ID# 167713
Wŏnju, , South Korea
Pusan National University Yang /ID# 167710
Yangsan, , South Korea
Yeosoo Hankook Hospital /ID# 168728
Yeosu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
clinical study report synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P16-666
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.